Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

"Our findings show that Zika virus isn't just passively transmitted." Scientist reveals disturbing way Zika virus affects ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Chinese scientists have developed a gene-editing technique to reduce corn plant height, enabling the creation of compact, ...

Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.

Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Biolumpivaxin is a single vaccination regimen given once a year to cattle and buffaloes above 3 months of age.

CRL's solid prospects in the DSA segment and strategic partnerships present a promising opportunity for investors.

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...

CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...

Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure ...